New TB vaccines are on the horizon, but their success is not guaranteed. World leaders pledged to deliver at least USD $2 billion annually for TB research, including vaccines, at the 2018 United [...]
The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB). Please read the press release
2021 Pipeline Report Tuberculosis Vaccines
From 20-22 April 2021 the virtual Global Forum on Tuberculosis (TB) Vaccines took place. Please read the meeting report.
We are delighted to announce that TBVI will once again organize its annual meeting in the Swiss mountains of Les Diablerets from 18-20 January 2022. We are currently compiling the program and [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: 0031 (0)6 1099 5196
